Molecular characteristics and successful management of a respiratory syncytial virus outbreak among pediatric patients with hemato-oncological disease

Table 1 Patients’ characteristics

Case	Nosocomial (Yes/No)	Age^a (years)	Sex (M/F)	Underlying Disease	RSV infection	WBC^b (per microliter)	RSV Treatment, Duration (days)	Additional antibiotic treatment	Oxygen (Yes/No)	RSV-related outcome	Virus shedding (days)
1	yes	16	M	Acute myeloid leukemia (recurrent)	LRTI	0	oral Ribavirin, 64	Yes	Yes	Remission	At least 63
2	yes	15	M	Severe aplastic anemia	LRTI	800	oral Ribavirin, 10	Yes	Yes	Remission	7
3	Yes	16	M	Acute lymphoid leukemia	URTI	1200	-	Yes	Yes (at night)	Remission	At least 6
4^c	Yes	9	M	Post-transplant Burkitt's leukemia	URTI	300	-	Yes	Yes	Remission	17^d
5	Yes	1	F	Neuroblastoma	URTI	9500	intravenous Ribavirin, 8	Yes	Yes	Remission	44
6	Possible	3	F	Ewing Sarcoma	URTI	500	-	Yes	Yes	Remission	5
7	Yes	10	F	Acute lymphoid leukemia	URTI	700	-	Yes	No	Remission	4
8	Possible	14	F	Acute lymphoid leukemia	URTI	290	oral Ribavirin, 8	Yes	No	Remission	13

^aAt time of virus detection
^bAt time (+/- 2 days) of virus detection
^cOnset of disease after discharge (treatment in home town hospital)
^dThere had been no in-house tests between first positive and first negative testing

ISSN: 2047-2994